The virulence of S. mutans in dental caries is strongly associated with the expression of glucosyltransferases, which are secreted enzymes responsible for the synthesis of extracellular polymers of glucan from sucrose. 8 A number of elegant studies conducted by different laboratories have shown that secreted glucosyltransferases prime the tooth enamel surface with glucans for bacterial adhesion via surface proteins that possess glucan-binding properties, and are primarily responsible for the formation of an extracellular matrix superstructure that anchors and supports the polymicrobial biofilm. [8] [9] [10] [11] To colonize extra-oral tissues, S. mutans appears to rely on the presence of a small number of surface-associated proteins that tightly interact with extracellular matrix proteins such as collagen, laminin and fibronectin. In particular, evidence is now accumulating that the CBPs Cnm and Cbm represent major virulence factors in extra-oral infections. 3, [12] [13] [14] [15] Expression of either Cnm or Cbm leads to robust adherence to collagen and laminin, invasion of nonphagocytic cells and increased virulence in both invertebrate and vertebrate models of systemic infection. 5, 12, 16, 17 Moreover, CBP + strains are more frequently isolated from the dental plaque of individuals with bacteremia and infective endocarditis, suggesting a correlation between the expression of these adhesins and the development of extra-oral infections. 16, 17 Although the distribution of Cbm + strains in oral isolates is lower than 3%, 18 a recent study found that the gene encoding Cbm was detected in five out of eight blood samples of infective endocarditis patients that tested positive for S. mutans DNA, whereas the cnm gene was detected once. 18 Like many other bacterial pathogens, S. mutans is recognized as a clonal species where multiple lineages with specific genome variations develop over generations, thereby providing evolutionary advantages to the population. [19] [20] [21] In many instances no major changes in the pathogenic potential of the organism are immediately noticed, but certain permutations can be associated with decreased or increased virulence. 22 For example, genetic alterations of the glucosyltransferase genes gtfB and/or gtfC can lead to differences in the ability of S. mutans to form biofilms in the presence of sucrose. 23, 24 Another classic example of such variations and their association with virulence are the rgp genes responsible for the synthesis of the rhamnose-glucose polysaccharide in S. mutans. 25, 26 Aside from providing the chemical basis for the grouping of strains into serotypes, the various rhamnose-glucose polysaccharide structures have been shown to differentially contribute to S. mutans virulence during systemic infections. 25, 26 With the advent of next-generation sequencing technologies, the number of S. mutans strains with avail- This increase has led to a better understanding of S. mutans physiology and evolution and has accelerated the discovery of novel genes involved in virulence. 24, 27, 28 Presently, the complete genome sequences of eight Cnm + strains are publicly available but no Cbm + strain has been sequenced to date. Considering that the pathogenic potential of S. mutans extends beyond the oral cavity, the identification and characterization of virulence factors in strains associated with extra-oral infections is of great relevance. Here, we present the complete and annotated genome sequence of LAR01, a Cbm + serotype e strain isolated from the oral cavity. In addition to the whole genome sequence, general phenotypic characteristics of LAR01 and the major properties of the cbm gene encoded by this strain were also investigated.
| MATERIAL S AND ME THODS

| Bacterial strains and culture conditions
All strains used in this study are listed in Table 1 
| Isolation and identification of S. mutans LAR01
Saliva was serially diluted and plated on Mitis Salivarius Agar supplemented with sucrose and bacitracin. 29 Plates were incubated at 37°C in a 5% CO 2 atmosphere for 48 hours. Colonies were screened by polymerase chain reaction (PCR) using S. mutans-specific primers 30 
TA B L E 1 Strains used in this study
Strains
Relevant genotype Source
Streptococcus mutans
LAR01
| Construction of recombinant strains
The cbm gene from S. mutans LAR01 was replaced with a non-polar kanamycin (NPKan) cassette, 35 which contains a promoterless aphA3 Km r gene with upstream stop codons in all three reading frames and without transcription termination sequences to allow transcription readthrough into downstream sequences, via allelic exchange.
Briefly, PstI sites were introduced to DNA fragments containing the 5ʹ and 3ʹ flanking regions of cbm using the primers listed in LAR01 was achieved using a ComX-inducing peptide (XIP) -based protocol developed for transformation of S. mutans UA159. 36 Briefly, cultures were grown overnight in a chemically defined medium containing 0.5% glucose (CDMG), 37 diluted 1:20 in fresh CDMG and grown to optical density at 600 nm (OD 600 ) of 0.1. Cultures were then transformed with 250 ng of the ligation mix in the presence of 100 nm XIP. 38 Transformants were selected on plates containing kanamycin and the desired mutation was confirmed by PCR sequencing of the cbm gene and flanking region. To complement the cbm mutant, the full-length cbm gene was amplified from LAR01 using primers containing BamHI (5ʹ primer) and XbaI (3ʹ primer) restriction sites and cloned onto the nisin-inducible shuttle vector pMSP3535 39 that had been previously digested with the same restriction enzymes. The resulting plasmid, pcbm, was used to transform the cbm mutant in the presence of XIP and create the strain CΔcbm. For heterologous expression of cbm in L. lactis, the pcbm was used to electroporate L. lactis NZ9800 strain following the protocol described elsewhere. 12 All strains (S. mutans and L. lactis) harboring pcbm or the empty pMSP35353 plasmids were selected on agar plates containing erythromycin. 
| Western blot analysis
| Biofilm assay
Biofilm development by different S. mutans reference strains (LAR01, UA159 and OMZ175) was measured in polystyrene 96-well 
| Stress tolerance assays
The ability of the S. mutans strains (LAR01, UA159 and OMZ175)
to survive extreme acid and peroxide challenges was determined using established protocols. 24 
| Growth competition assays
The ability of S. mutans strains to inhibit growth of their counterparts was determined using a growth competition assay on solid media. Briefly, overnight cultures of S. mutans UA159, OMZ175
and LAR01 were diluted 1:25 in BHI and grown to OD 600 of 0.3. Then, a 15-μL aliquot of the early colonizer was spotted on a BHI agar plate incubated at 37°C, 5% CO 2 for 24 hours.
The following day, the plates were exposed to UV light (254 nm, ~ 3000 μwatts cm −2 ) for 20 minutes to kill the early colonizer.
Then, 15 μL of the late colonizer overnight culture, also grown in BHI, was spotted and the plates were incubated for an additional 24 hours. A deferred antagonism assay was further performed to determine the ability of S. mutans strains to inhibit the growth of S. gordonii and L. lactis, indicator strains for mutacin IV and V, respectively. Cultures of the different S. mutans strains were grown in BHI to an OD 600 of 0.3 when a 15-μL aliquot was spotted onto BHI agar and incubated for 24 hours. Following incubation, plates were exposed to UV light for 20 minutes to ensure that subsequent antagonism was not due to actively growing S. mutans cells. Then, 500 μL of an overnight culture of S. gordonii DL-1 (mutacin IV sensitive) or L. lactis ATCC 11454 (mutacin V sensitive) grown in BHI as previously described was added to 5 mL soft (0.75%) BHI agar, spread as an overlay and incubated for another 24 hours before zones of growth inhibition around the S. mutans spots were measured. 42 Growth competition assays were also performed in the presence of aminopeptidase (Sigma-Aldrich) to prove that inhibition zones were due to mutacin activity. For this, early colonizers were spotted as described above and incubated for 24 hours. After exposure to UV light for 20 minutes, aminopeptidase (64 μg) was spotted on the side of the early colonizer and plates were incubated for 1 hour at 37°C.
Then the late colonizer was spotted exactly over the peptidase site and the plates were incubated for an additional 24 hours before visualization. at 37°C, and appearance (signs of melanization) and survival were recorded at selected intervals. Larvae were scored as dead when they displayed no movement in response to touch. Kaplan-Meier killing curves were plotted and estimation of differences in survival were compared using the log-rank test. A P value ≤.05 was considered significant.
| Extracellular matrix binding and human coronary artery endothelial cell invasion
| Galleria mellonella infection
| Immunofluorescence labeling of Cnm
Cultures of recombinant L. lactis expressing Cbm through pcbm were used for cellular localization of Cbm. Cells grown to mid-exponential phase were washed in PBS and incubated in the presence of antirCnmA antibody (1:100) followed by anti-rabbit Alexa-488 conjugate antibody (1:100) with three washes between each antibody exposure. Cell-antibody complexes were visualized using an Olympus BX41 fluorescent microscope and images were captured with the QCAPture Software.
| Real-time quantitative RT-PCR
RNA extraction and real-time reverse transcription quantitiative PCR analysis were performed as previously described. 44 Overnight cul- using an RNeasy minikit (Qiagen). RNA concentrations were determined using a NanoVue Plus spectrophotometer (GE Life Sciences).
Reverse transcription and real-time PCR were carried out as previously described 45 using cbm-specific primers (Table 2) .
| RE SULTS
| Isolation and whole genome sequencing of S. mutans LAR01
The LAR01 isolate was obtained from a saliva sample of a caries experienced adult female subject with no obvious signs of active oral diseases (eg dental caries, periodontitis). Upon selection and differentiation on Mitis Salivarius Agar supplemented with sucrose and bacitracin, molecular identification using species-and serotypespecific primers confirmed this oral isolate as a serotype e S. mutans strain (data not shown). In subsequent PCR analysis, LAR01 tested negative for the presence of cnm but positive for cbm.
The LAR01 genome is a single circular chromosome of 2.1 Mb with a GC content of 36.96% (Figure 1) Previous studies using comparative analysis identified that there is a large degree of genome rearrangement within S. mutans strains 27, 46 and the LAR01 genome was no exception. A gene annotated file is provided as part of the Supplementary material (Table S1 ). However, this open reading frame is truncated at amino acid 704, only two amino acids apart from the downstream LPxTG motif, in a few sequenced strains, including in UA159 (Smu_1213c; nadN) ( Figure S1 ).
F I G U R E 1 Circular representation of the genome of Streptococcus mutans LAR01. Outermost circle indicates the distances from the putative origin of replication. Blue circle represent genes in the forward strand (+) and red circle represent genes in the reverse strand (−).
Secreted genes are represented in green whereas orange indicates genes that are unique to LAR01 in relation to UA159. Innermost circle represents the % G + C with more and less than average shown as light blue and purple, respectively
The LAR01 genome was also found to harbor genes associated with competence pathways including the transcriptional regulator comR, comS (ComX-inducing peptide, XIP), comC (competencestimulating peptide, CSP), the competence factor comX, and all late competence genes required for natural transformation, which confirms previous studies that the CSP-and XIP-signaling pathways are widespread in S. mutans. Indeed, during genetic manipulations of LAR01 for the construction of cbm deletion (Δcbm) and
Δcbm complemented strains, we observed that natural transformation of LAR01 increased by several orders of magnitude in the presence of synthetic CSP or XIP (data not shown). In addition, the LAR01 genome harbors two previously characterized mutacins: 51 non-lantibiotic mutacin VI and lantibiotic mutacin K8 (Table 3 ).
| Genetic organization of the cbm locus
The cbm gene in LAR01 encodes a 56-kDa protein with a conserved N-terminal collagen-binding domain (A-domain) and a threonine-rich C-terminus domain (B-domain). 18 The Cbm protein of LAR01 shared 80% similarity with the OMZ175 Cnm protein with the largest degree of conservation occurring at the collagenbinding A-domain ( Figure S2 ). Interestingly, the 3ʹ end of the cbm gene in LAR01 is flanked by the same core genes as cnm in OMZ175 and in other cnm + strains 17, 27, 28 (Figure 2 ). Specifically, after the cnm stop codon is the pgfS gene, which encodes for a glycosyltransferase involved in the post-translational modification of Cnm. 40 When using the glycosylation prediction software NetOGlyc, 52 like the Cnm B-domain, the threonine-rich B-domain of Cbm protein is predicted to have nearly 100 threonine/serine residues subjected to undergo modification through O-glycosylation ( Figure S3 ). More recently, we discovered that the three genes immediately downstream pgfS, named pgfM1, pgfE and pgfM2, are part of the pgf operon and are also involved in the modification of Cnm (data not shown). In LAR01, cbm is followed by pgfS, pgfM1 and pgfE but a large 29.1-kb DNA insertion encoding 30 additional genes separates pgfE from pgfM2 ( Figure 2 ).
Group
LAR01 Comparative producer
Other producer strains Interestingly, genes coding for components of a type VII seven secretion system (T7SS) are found within this DNA insertion between the core genes pgfE and pgfM2.
| Characterization of virulence-related traits in LAR01
The cariogenic potential of S. mutans is strongly associated with its ability to form biofilms on tooth surfaces and to tolerate environmental stresses, particularly acid and oxidative stresses. Here, we used the UA159 (serotype c, cnm The genome of LAR01 encodes genes for mutacin VI and K8 (Table 3) . Using UA159 and OMZ175 as benchmark strains, we first tested the capacity of each individual strain to inhibit Absence of growth inhibition after addition of aminopeptidase confirmed that inhibition zones were due to mutacin activity. E, F, Deferred antagonism assays. Cultures of S. mutans were grown on brain-heart infusion (BHI) agar plates for 24-hour incubation and a soft BHI agar overlay containing Streptococcus gordonii (E) or Lactococcus lactis (F) cells was incubated for additional 48 hours before the zone of inhibition was recorded. All experiments were performed at least in triplicate and asterisks indicate statistical significance (P ≤ .05) the growth of another. We found that LAR01 and OMZ175
can inhibit the growth of UA159 whereas LAR01 and OMZ175 modestly inhibit the growth of each other ( Figure 3D ). On the other hand, UA159 was unable to inhibit the growth of LAR01 or OMZ175. Next, we investigated the ability of LAR01 to inhibit the growth of S. gordonii (a closely related species), a target of mutacin VI, and L. lactis, which serves as indicator strains for wide-spectrum mutacins such as mutacin K8. Growth of S. gordonii was modestly inhibited by all three strains ( Figure 3E) even though UA159 produces another non-lantibiotic (mutacin IV) active against S. gordonii. Finally, UA159 and OMZ175
can also synthesize mutacin V, a non-lantibiotic mutacin active against L. lactis. Growth of L. lactis was strongly inhibited by both strains with a slightly larger zone of inhibition surrounding OMZ175 when compared with UA159 ( Figure 3F ), possibly because OMZ175 also produces mutacin I. Finally, LAR01 could also inhibit L. lactis growth ( Figure 3F ) albeit not to the same extent as the UA159 and OMZ175 strains, suggesting that mutacin K8 may not be as potent as mutacin V against L. lactis. Of note, inhibition zones are no longer seen in the presence of aminopeptidase ( Figure S4 ), confirming that mutacins are responsible for the growth inhibition observed.
| Characterization of the LAR01∆cbm strain and heterologous expression of Cbm in Lactococcus lactis
Because the collagen-binding domain of Cbm shares high levels (80%) of similarity with its Cnm counterpart, we expected the antiCnm antibody, raised against the Cnm collagen-binding domain, to cross-react with Cbm. Indeed, Western blot analysis identified a band of ~150 kDa in the LAR01 lysate that was absent in the ∆cbm strain but restored in the complemented strain, although with lower protein expression levels than those of the wild-type ( Figure 4A ).
As the expression plasmid pMSP3535 is leaky and induction of the complemented strain with nisin (16 ng mL −1 ) did not seem to enhance protein expression ( Figure 4A ) nor its ability to bind collagen and laminin (data not shown), all subsequent experiments were performed using non-induced cultures.
Similar to Cnm, strains expressing Cbm have been shown to avidly bind to collagen and laminin and mediate invasion of endothelial cells. 17 In fact, LAR01 was able to bind collagen or laminin and invade HCAECs at levels that were similar to those found for the In addition to the cell-characterized surface proteins, LAR01
| D ISCUSS I ON
possesses the cell-wall-anchored protein S_00879, coding for a pu- surprising. T7SS was initially identified in Mycobacterium tuberculosis but it is also found in other Gram-positive bacteria such as Staphylococcus aureus. [55] [56] [57] [58] In M. tuberculosis, T7SS was demonstrated to contribute to virulence and host cell membrane lysis. 59 In S. aureus, in addition to contribute to the pathogenesis of abscesses and to induce apoptosis in epithelial cells with subsequent release of intracellular S. aureus, 60, 61 this T7SS was also associated with growth inhibition of competitor bacteria. 62 More recently, genes for this T7SS
were identified in a small subset of S. mutans strains (8 out of 57). 24 However, this is the first time that T7SS genes are found in the genome of an S. mutans strain encoding bona-fide CBPs such as Cbm.
Although strains that contained the genes for the T7SS did not display greater virulence in the G. mellonella invertebrate model, 24 additional studies are necessary to determine if the system is functional and, if so, identify effector proteins secreted through this pathway and their possible association with virulence or competition with other bacteria.
To thrive in dental plaque, S. mutans must outcompete commensal streptococci (eg mitis streptococci) as well as members of its own species. 63 An important attribute of S. mutans is its capacity to produce inhibitory substances such as lactic acid and bacteriocins. To this end, S. mutans strains produce a broad range of lantibiotic and non-lantibiotic bacteriocins, known as mutacins, although distribution of mutacins can vary greatly among strains. 64 Our findings suggest that LAR01 produces mutacin VI and K8. Mutacin VI is non-lantibiotic mutacin widespread in S. mutans strains and active against closely related species such as non-mutans streptococci.
However, mutacin K8 is a wide spectrum lantibiotic mutacin found in a small number of strains. 65 Although the genome of UA159 does not encode wide-spectrum lantibiotics, mutacin K8 produced by LAR01 and mutacin I produced by OMZ175 are likely responsible for the growth inhibition of UA159. Another important virulenceassociated trait of S. mutans is its ability to form robust biofilms on tooth surfaces, to withstand the acidic environment associated with the cariogenic environment and to cope with reactive oxygen species that commensal streptococci use to fight back S. mutans. 63 Here, we show that LAR01 is able to withstand acid and oxidative stresses just like our benchmark strains. However, LAR01
was able to form more biofilm biomass than the CBP − strain UA159.
Interestingly, Cnm + were previously reported to form less biofilm biomass in general than UA159, 24 but previous reports on Cbm + S. mutans did not evaluate the biofilm phenotype of these strains.
Hence, studies with additional strains are required to make an inference on whether Cbm + strains form more biofilms in general.
Our findings confirm that LAR01 encodes a functional CBP that, like Cnm, migrates at a much higher molecular weight than the predicted size. Therefore, the presence of a threonine-rich repeat domain, the prediction that Cbm undergoes glycosylation, the genetic linkage of cbm with pgf genes, and the aberrant migration of Cbm strongly indicate that, like Cnm, Cbm undergoes post-translational glycosylation. In the Cnm + OMZ175, the pgf glycosylation machinery is comprised of four genes (pgfS, pgfM1, pgfE and pgfM2) (data not shown) and all genes are essential for Cnm glycosylation. The fact that there is a 29.1-kb insertion between pgfE and pgfM2 indicates that pgfM2 may not be essential for Cbm modification and/or that pgfM2 may also work in concert with different glycosylation machineries.
Further studies with pgf gene inactivations in LAR01 will reveal which genes are required for Cbm glycosylation. Also, as future genomes of Cbm + strains become available, it would be valuable to determine whether this genetic arrangement is conserved among these strains. 
| Concluding remarks
Although a role for CBPs in caries has been suggested, 54 6 Also, Cnm was shown to inhibit activation of the classical complement pathway through direct binding to the collagen-like domain of component C1q, 73 and as Cbm has a high degree of homology with Cnm, we speculate a similar function for the former. Hence, expression of CBPs by S. mutans is an important and underestimated strategy contributing to the establishment and/or progression of recurrent and chronic systemic infections. 6 In this report, we obtained the whole genome sequence of LAR01, the first Cbm + strain of S. mutans to be fully sequenced. We also conducted a series of assays to compare the characteristics of LAR01 against other well-characterized strains and showed that Cbm contributed to different tissue colonization strategies and survival. Overall, the whole genome sequence of LAR01 provides further information to the pan-genome of S. mutans and grants further opportunities to understand the genomic fluidity of this important human pathogen.
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